Daiichi Sankyo

Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients. Through the outstanding knowledge and commitment of our approximately 17,000 employees worldwide, we create innovative new and generic medicines, and new methods of drug discovery and delivery. We share a passion for innovation, as well as compassion for the patients around the world who are in need of our medicines.
Parsippany Troy Hills, US
Size (employees)
3,168 (est)
Daiichi Sankyo is headquartered in Parsippany-Troy Hills, US

Daiichi Sankyo Office Locations

Daiichi Sankyo has an office in Parsippany-Troy Hills
Parsippany-Troy Hills, US (HQ)
2 Hilton Ct

Daiichi Sankyo Financials and Metrics

Daiichi Sankyo Financials


Market capitalization (27-Oct-2017)

14.7 b

Closing share price (27-Oct-2017)

Daiichi Sankyo's current market capitalization is $14.7 b.
Show all financial metrics

Daiichi Sankyo Market Value History

Daiichi Sankyo's Web-traffic and Trends

Daiichi Sankyo Online and Social Media Presence

Daiichi Sankyo News and Updates

FiercePharmaAsia—GSK’s neurology R&D hub, Pfizer-Astellas’ aborted Xtandi mission, Daiichi Sankyo’s Benicar settlement

GlaxoSmithKline will soon close its global neuroscience R&D hub located in Shanghai, Pfizer and Astellas have decided to discontinue research into Xtandi's usage in breast cancer, Daiichi Sankyo is offering $300 million to settle about 2,300 lawsuits around Benicar and other news items from Asia…

Daiichi Sankyo Company Life and Culture

You may also be interested in